RecruitingPhase 4NCT03735563
Premedication for Less Invasive Surfactant Administration
Studying Rare genetic respiratory disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Oulu
- Principal Investigator
- Riitta Marttila, MD, docentOulu University and Oulu University Hospital
- Intervention
- Ketamine(drug)
- Enrollment
- 40 target
- Eligibility
- All sexes
- Timeline
- 2019 – 2026
Study locations (1)
- Oulu University Hospital, Oulu, Finland
Collaborators
Oulu University Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03735563 on ClinicalTrials.govOther trials for Rare genetic respiratory disease
Additional recruiting or active studies for the same condition.